Loading...
Loading...
Among the 4 tracked institutional investors we monitor, LIMN (LIMINATUS PHARMA INC.) is held with a combined value of $53.11K across 148,826 shares. The largest holder is VANGUARD GROUP INC with a position worth $44.79K. 2 funds reduced their position.
Total Institutional Value
$53.11K
Total Shares Held
148,826
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $44.79K | 0.00% | - |
| 2 | CITADEL ADVISORS LLC | $6.19K | 0.00% | -91.7% |
| 3 | STATE STREET CORP | $2.10K | 0.00% | - |
| 4 | BlackRock, Inc. | $35 | 0.00% | -97.6% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of LIMN with a position worth $44.79K, representing 0.00% of their portfolio. In total, 4 institutional investors hold LIMN with a combined value of $53.11K.
Institutional investors hold $53.11K worth of LIMN stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $44.79K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LIMN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LIMN positions.
Last Close
$3.12
2026-10-21
YTD
-90.3%
0% of 52-week range